According to Gracell Biotechnologies's latest financial reports the company's current EPS (TTM) is -$1.26. In 2022 the company made an earnings per share (EPS) of -$1.33 a decrease over its 2021 EPS that were of -$1.07.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.26 | -5.05% |
2022 | -$1.33 | 24.79% |
2021 | -$1.07 | -6.49% |
2020 | -$1.14 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | 72.38% | ๐บ๐ธ USA |